AzTrials
AzTrials

General AnesthesiaPhase 4NCT01995214

Sevoflurane and Propofol Anesthesia on Postoperative Delirium

A Phase 4 study testing Propofol and Sevoflurane in people with General Anesthesia and Geriatric Patient, run by Huazhong University of Science and Technology at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Delirium is defined as an acute onset and fluctuating course of mental status change with inattention and an altered level of consciousness. Delirium in the postoperative period can be divided into emergence delirium and postoperative delirium, based on the time of onset (Silverstein et al., 2007).Postanaesthesia… Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
General Anesthesia, Geriatric Patient
What is being tested?
Propofol and Sevoflurane
Could I receive a placebo?
No, everyone receives an active treatment
How many people
500 participants
Where
1 siteChina
Study dates
Jun 2013to Dec 2013
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • American Society of Anesthesiologists Physical Status classification (ASA_PS) class I-III
  • Aged 60 years or above
  • Elective major surgery under general anesthesia

Who cannot join

  • ASA_PS>=IV
  • Aged under 60 yr old
  • Body mass index (BMI) >30
  • Neurologic disease
  • Cardiac surgery and neurologic surgery
  • Anticonvulsant drugs
  • Chronic analgesics intake
  • Participating in the investigation of another study

Trial locations and contacts

1 site in 1 country.

Wei Mei, MD., PhD contact

00862783663173

wmei@tjh.tjmu.edu.cn

China1 site, 1 recruiting
  • Tongji Hospital

    Wuhan, Hubei, 430030

    Wei Mei, MD., PhD., 00862783663173, wmei@tjh.tjmu.edu.cn

    Recruiting

Other trials in China

About this study

Official title: Comparison of Sevoflurane and Propofol Anesthesia on Postoperative Delirium in Geriatric Patients

Delirium is defined as an acute onset and fluctuating course of mental status change with inattention and an altered level of consciousness. Delirium in the postoperative period can be divided into emergence delirium and postoperative delirium, based on the time of onset (Silverstein et al., 2007).Postanaesthesia delirium is a frequent and potentially serious problem affecting the safety of patients and medical personnel. Clinical studies demonstrated that postoperative delirium is associated with worse outcomes such as prolonged hospital stay, postdischarge institutionalization, and increased mortality (Ely et al., 2004a; Thomason et al., 2005; Robinson et al., 2009). Multiple factors may contribute to the development of postoperative delirium, including patient's medical condition, administration of anesthetics or analgesics and degree of operative stress (Yildizeli et al., 2005; Robinson \& Eiseman, 2008; Deiner \& Silverstein, 2009). Sevoflurane anesthesia have been reported to be associated with more emergence delirium in pediatric patients, when compared with propofol anesthesia. It is not clear if propofol anesthesia will benefit the geriatric patients on postoperative delirium, when compared with sevoflurane anesthesia. We hypothesize that propofol anesthesia will reduce the rate of postoperative delirium by 50% when compared with sevoflurane anesthesia.

Being tested
Propofol, Sevoflurane
Keywords
Postoperative delirium, Geriatric, General anesthesia, Propofol, Sevoflurane
Medical subject headings
Emergence Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PropofolDrug

    Anesthesia maintenance with propofol+remifentanil guided by Narcotrend index monitoring.

  • SevofluraneDrug

    Anesthesia maintenance with sevoflurane+remifentanil guided by Narcrotrend index monitoring.

Study groups in NCT01995214
Study groupRoleWhat they receive
PExperimentalAnesthesia maintenance with propofol+remifentanil
Receives: Drug: Propofol
SExperimentalAnesthesia maintenance with sevoflurane+remifentanil
Receives: Drug: Sevoflurane

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative delirium

    Postoperative delirium was determined by Confusion Assessment Method (CAM) at 24 postoperative hours

    Measured: at 24 postoperative hours

Secondary outcomes (6)
  1. Length of postanesthesia care unit (PACU) stay

    Length of PACU stay (min)

    Measured: up to 2 hours after PACU admitting

  2. Hemodynamic parameters

    Hart frequency, systolic blood pressure, diastolic blood pressure

    Measured: 5min, 10min, 20min, 30min after induction, 5min, 10min, 20min, 30min after skin incision, 5min, 10min, 20min, 30min before incision closure

  3. Incidence of postoperative nausea and vomiting

    Incidence of postoperative nausea and vomiting

    Measured: 24 postoperative hours

  4. Quality of recovery determined by quality of recovery (QOR-40; maximum score 200) score

    Quality of recovery determined by QOR-40

    Measured: 1,2,3,7 postoperative days

  5. Postoperative delirium

    Postoperative delirium was determined by CAM every day at 2st, 3st, 7st postoperative days

    Measured: 2st, 3st, 7st postoperative days

  6. Postoperative Stroke

    Postoperative Stroke will be determined by National Institutes of Health Stroke Scale (NIHSS)

    Measured: 1st, 2st, 3st, 7st postoperative days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Nov 2013 (estimated)
  2. Study startJun 2013
  3. Primary completionDec 2013 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01995214
Sponsor's protocol ID
TJMZK20130602
Status last verified
Nov 2013
First submitted
13 Nov 2013
Last updated
26 Nov 2013
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Propofol and Sevoflurane in people with General Anesthesia and Geriatric Patient, run by Huazhong University of Science and Technology at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Nov 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Wei Mei, MD., PhD (00862783663173, wmei@tjh.tjmu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative delirium (time frame: at 24 postoperative hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Nov 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in